InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Farley Chele Chiavacci. Director active across 1 company, notably CONDUIT PHARMACEUTICALS INC.. Aggregated, 4 disclosures have been logged. Activity tracked since 18 November 2024. The latest transaction was disclosed on 30 March 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
4 of 4 declarations